camptothecin has been researched along with Leukemia, Lymphoid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, W; LaVoie, EJ; Liu, AA; Liu, LF; Satyanarayana, M; Tsai, YC | 1 |
| Adamson, RH; Mead, JA; Sieber, SM | 1 |
| Akutsu, M; Inoue, Y; Kano, Y; Miura, Y; Sakamoto, S; Suda, K; Suzuki, K; Yoshida, M | 1 |
| Darzynkiewicz, Z; Del Bino, G; Skierski, JS | 1 |
| Andoh, T; Bolund, L; Bonven, BJ; Ishii, K; Kjeldsen, E; Okada, K; Westergaard, O | 1 |
| Andoh, T; Ikegami, Y; Ishii, K; Kusunoki, Y; Okada, K; Suzuki, Y; Takemoto, Y | 1 |
| Kessel, D; Spataro, A | 1 |
1 review(s) available for camptothecin and Leukemia, Lymphoid
| Article | Year |
|---|---|
Pharmacology of antitumor agents from higher plants.
Topics: Animals; Antineoplastic Agents, Phytogenic; Aporphines; Camptothecin; Carcinoma, Squamous Cell; Chemical Phenomena; Chemistry; Etoposide; Humans; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Maytansine; Melanoma; Naphthoquinones; Nasopharyngeal Neoplasms; Neoplasms; Neoplasms, Experimental; Phenanthrenes; Structure-Activity Relationship; Teniposide; Vinblastine; Vincristine | 1976 |
6 other study(ies) available for camptothecin and Leukemia, Lymphoid
| Article | Year |
|---|---|
11-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridine derivatives as novel topoisomerase I-targeting agents.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; DNA Topoisomerases, Type I; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Leukemia, Lymphoid; Phenanthridines; Structure-Activity Relationship; Topoisomerase I Inhibitors | 2008 |
Effects of CPT-11 in combination with other anti-cancer agents in culture.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Death; Cell Division; Dose-Response Relationship, Drug; Drug Synergism; Humans; In Vitro Techniques; Irinotecan; Leukemia, Lymphoid; Tumor Cells, Cultured | 1992 |
Diverse effects of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, MOLT-4) and myelogenous (HL-60, KG1) leukemic cells.
Topics: Animals; Camptothecin; DNA, Neoplasm; Humans; Interphase; Leukemia L1210; Leukemia, Lymphoid; Leukemia, Myeloid; Mice; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1990 |
Characterization of a camptothecin-resistant human DNA topoisomerase I.
Topics: Base Sequence; Camptothecin; Cell Line; DNA Topoisomerases, Type I; Drug Resistance; Humans; Kinetics; Leukemia, Lymphoid; Substrate Specificity | 1988 |
Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I.
Topics: Camptothecin; Cell Line; DNA Topoisomerases, Type I; DNA, Superhelical; Drug Resistance; Humans; Immunosorbent Techniques; Leukemia, Lymphoid; Mutation; Nucleic Acid Conformation; Peptide Mapping; Plasmids | 1987 |
The effects of camptothecin on mammalian DNA.
Topics: Animals; Camptothecin; Carbon Radioisotopes; Cell Line; Centrifugation, Density Gradient; DNA; Formamides; Hydrogen-Ion Concentration; L Cells; Leukemia, Lymphoid; Mammals; Mice; Molecular Weight; Spectrophotometry, Ultraviolet; Sucrose | 1973 |